HNI vs MasterBrand
HNI and MBC side by side, both in consumer discretionary. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How HNI and MBC compare
HNI is the larger company, worth 2.8 times as much as MasterBrand ($3.4B against $1.2B).
HNI grew revenue faster over the last twelve months (70.1% versus −0.01% for MasterBrand).
HNI keeps more of each dollar of sales as profit, with a net margin of 0.10% compared with −3.5% at MasterBrand.
HNI pays a dividend yielding 2.2%; MasterBrand does not pay one.
HNI scores higher on the StockData Score (7 against 4 for MasterBrand), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | HNI | MBC |
|---|---|---|
| Size and price | ||
| Market cap | $3.4B | $1.2B |
| Share price | $46.75 | $6.02 |
| Change, 1 year | 19.3% | −40.7% |
| Change, 5 years | 14.7% | −42.7% |
| Beta (5Y) | 0.91 | 1.27 |
| Employees | 20K | 12K |
| StockData Score | ||
| Total score | 7 (better) | 4 |
| Valuation score | 0 | 3 (better) |
| Growth score | 1 (better) | 0 |
| Performance score | 3 (better) | 0 |
| Health score | 1 | 1 |
| Dividend score | 2 (better) | 0 |
| Valuation | ||
| P/E | 425× | – |
| P/S | 0.8× | 0.4× (better) |
| P/B | 1.9× | 0.6× (better) |
| EV/EBITDA | 16.2× | – |
| P/FCF | – | 16.5× |
| FCF yield | – | 6.1% |
| Fair value | $24.52 | $9.75 |
| Margin of safety | −90.7% | 38.3% (better) |
| Growth | ||
| Revenue growth (TTM) | 70.1% (better) | −0.01% |
| Revenue growth, 5Y average | 7.7% | – |
| Net income growth (TTM) | −97.1% (better) | −203% |
| EPS growth (TTM) | −96.4% (better) | −196% |
| EPS growth, 5Y average | 2.5% | – |
| Profitability | ||
| Gross margin | 41.0% (better) | 26.9% |
| Operating margin | 2.0% (better) | −1.1% |
| Net margin | 0.10% (better) | −3.5% |
| FCF margin | – | 2.7% |
| Return on equity | 0.33% (better) | −5.8% |
| Return on invested capital | 2.1% (better) | −0.93% |
| Financial health | ||
| Debt / equity | 0.76 | 0.71 (better) |
| Net debt / EBITDA | 4.41 | – |
| Interest coverage | – | −0.4× |
| Current ratio | 1.36 | 1.76 (better) |
| Altman Z-score | 1.74 (better) | 1.41 |
| Piotroski F-score | 6 | 6 |
| Dividends and buybacks | ||
| Dividend yield | 2.2% | – |
| Payout ratio | 1937% | – |
| Years of dividend growth | 15 | – |
| Dividend growth, 5Y average | 2.0% | – |
| Buyback yield | 0.01% (better) | 0.00% |
| Shareholder yield | 2.2% (better) | 0.00% |
| Ownership | ||
| Held by institutions | 87.8% | 109% |
| Held by insiders | 1.9% | 2.1% |
| Insider net buying, 12 months | −$4.8M | −$157K (better) |
| Short interest, % of float | 5.4% | 11.4% |
Go deeper
- HNI stock overview
- HNI income statement
- HNI valuation and score
- MBC stock overview
- MBC income statement
- MBC valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.